Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Glaxosmithkline Pharmaceuticals LtdIndustry : Pharmaceuticals - Multinational
BSE Code:500660NSE Symbol: GLAXOP/E(TTM):55.81
ISIN Demat:INE159A01016Div & Yield %:1.53EPS(TTM):37.52
Book Value(Rs):91.3566062Market Cap ( Cr.):35471.08Face Value(Rs):10
    Change Company 
(Rs In Cr)
 Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
SOURCES OF FUNDS :      
Share Capital 169.41169.41169.41169.41169.4184.70
Reserves Total 1583.592508.211327.711670.631973.011995.25
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds1753.002677.621497.121840.042142.422079.95
Secured Loans 0.000.000.000.000.000.00
Unsecured Loans 15.5420.0834.630.180.580.99
Total Debt15.5420.0834.630.180.580.99
Other Liabilities254.22263.00260.29289.39315.72288.44
Total Liabilities2022.762960.701792.042129.612458.722369.38
APPLICATION OF FUNDS :      
Gross Block 635.93593.89602.891454.59561.30408.14
Less : Accumulated Depreciation 305.99263.26216.00696.53129.6983.57
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 329.94330.63386.89758.06431.61324.57
Lease Adjustment 0.000.000.000.000.000.00
Capital Work in Progress20.3130.5013.21120.121002.64922.90
Producing Properties0.000.000.000.000.000.00
Investments 542.78390.0924.4924.4924.5547.67
Current Assets, Loans & Advances      
Inventories 437.70512.71523.34483.03486.49500.18
Sundry Debtors 192.38205.24215.6099.80120.49146.96
Cash and Bank1150.732479.111157.681066.411155.331279.69
Loans and Advances 167.62108.05274.71107.54228.87236.21
Total Current Assets1948.433305.122171.331756.781991.182163.05
Less : Current Liabilities and Provisions      
Current Liabilities 590.941046.53866.70559.871205.151344.46
Provisions 713.99615.36438.35442.04245.32251.18
Total Current Liabilities1304.941661.901305.051001.921450.471595.64
Net Current Assets643.491643.22866.28754.86540.71567.41
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets151.38131.67117.24126.0984.60119.26
Deferred Tax Liability18.2018.8915.5717.2424.1216.20
Net Deferred Tax133.18112.78101.67108.8560.48103.06
Other Assets353.06453.48399.49363.22398.72403.78
Total Assets2022.762960.701792.032129.602458.712369.39
Contingent Liabilities350.59351.10485.78471.42512.80637.85